Cutia Therapeutics

2487.HK·HKSE·Healthcare
Compare
0.710+0.020 (+2.90%)today
At close: Nov 5, 2:35 PM HKT · May be delayed up to 15 min · HKD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.690
Open0.690
Day range0.6900.710
52-week range0.6007.270
Off day high0.00%
Off 52-week high−90.23%
Volume3.00K
Avg. volume (3M)490.46K
Market cap266.35M
EPS (TTM)-0.8700
Forward P/E4.32
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.78
Shares outstanding375.14M
Short interest—
Earnings date—
Analyst target7.745
Profit margin−84.55%

Against its peers

Compare in full ›
2487.HK FBIO SLGL VYT.MC 9939.HK QTTB
Market cap 266.35M 65.70M 216.08M 112.86M 642.90M 268.42M
P/E (TTM) — 0.7 — 27.3 — 2.5
Forward P/E 4.3 -1.1 -8.2 19.2 -0.6 -8.8
Price/book 0.3 0.4 4.5 8.7 5.1 2.0
Dividend yield — — — — — —
1-year change −89.22% −21.83% +106.22% +111.43% −20.69% +286.64%
Today +2.90% +1.55% +3.43% +1.35% −4.71% +2.40%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All 2487.HK news ›
markets.businessinsider.com··2 outletsPositive

Fangzhou and Cutia Therapeutics Partner to Advance AI-Powered Dermatology and Chronic Health Management

GUANGZHOU, China, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven I... Fangzhou and Cutia Therapeutics Partner to Advance AI-Powered Dermatology and Chronic…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

2mentions in 30 days
2with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance